Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 25 studies | 31% ± 11% | |
macrophage | 23 studies | 33% ± 17% | |
classical monocyte | 23 studies | 38% ± 13% | |
non-classical monocyte | 22 studies | 36% ± 15% | |
monocyte | 17 studies | 37% ± 18% | |
microglial cell | 12 studies | 46% ± 16% | |
fibroblast | 11 studies | 30% ± 10% | |
neutrophil | 10 studies | 32% ± 11% | |
myeloid cell | 10 studies | 35% ± 15% | |
mast cell | 9 studies | 29% ± 8% | |
endothelial cell of lymphatic vessel | 8 studies | 33% ± 15% | |
conventional dendritic cell | 7 studies | 22% ± 10% | |
adipocyte | 7 studies | 33% ± 14% | |
dendritic cell | 7 studies | 34% ± 9% | |
capillary endothelial cell | 6 studies | 23% ± 5% | |
vein endothelial cell | 6 studies | 32% ± 20% | |
pericyte | 5 studies | 22% ± 6% | |
endothelial cell of artery | 5 studies | 23% ± 7% | |
alveolar macrophage | 5 studies | 49% ± 22% | |
respiratory goblet cell | 4 studies | 28% ± 10% | |
mononuclear phagocyte | 4 studies | 43% ± 9% | |
mesothelial cell | 4 studies | 32% ± 9% | |
hematopoietic precursor cell | 3 studies | 30% ± 6% | |
common myeloid progenitor | 3 studies | 23% ± 4% | |
intermediate monocyte | 3 studies | 47% ± 16% | |
endothelial cell of vascular tree | 3 studies | 44% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 7003.22 | 577 / 578 | 95% | 7.95 | 1100 / 1155 |
breast | 99% | 4294.27 | 456 / 459 | 85% | 4.88 | 952 / 1118 |
esophagus | 86% | 1519.65 | 1244 / 1445 | 95% | 9.41 | 173 / 183 |
prostate | 97% | 2136.50 | 237 / 245 | 82% | 2.29 | 411 / 502 |
thymus | 97% | 2067.95 | 633 / 653 | 81% | 2.15 | 488 / 605 |
stomach | 93% | 1852.19 | 333 / 359 | 81% | 5.48 | 231 / 286 |
uterus | 95% | 1958.74 | 162 / 170 | 78% | 3.68 | 358 / 459 |
bladder | 100% | 2417.62 | 21 / 21 | 70% | 2.86 | 352 / 504 |
intestine | 94% | 1815.90 | 909 / 966 | 69% | 3.51 | 364 / 527 |
adrenal gland | 94% | 1381.42 | 242 / 258 | 67% | 1.87 | 154 / 230 |
kidney | 73% | 1102.98 | 65 / 89 | 77% | 4.01 | 695 / 901 |
skin | 80% | 2179.35 | 1451 / 1809 | 65% | 2.88 | 305 / 472 |
ovary | 76% | 1029.77 | 136 / 180 | 59% | 1.51 | 253 / 430 |
brain | 24% | 255.96 | 645 / 2642 | 96% | 3.55 | 677 / 705 |
pancreas | 20% | 207.34 | 66 / 328 | 93% | 8.48 | 166 / 178 |
adipose | 100% | 6033.29 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 10533.95 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 13689.82 | 903 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 7.77 | 43 / 45 |
heart | 91% | 1685.72 | 783 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 90% | 2180.76 | 1207 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 4.83 | 26 / 29 |
liver | 24% | 255.94 | 54 / 226 | 24% | 0.58 | 99 / 406 |
muscle | 30% | 294.68 | 243 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002755 | Biological process | MyD88-dependent toll-like receptor signaling pathway |
GO_0042177 | Biological process | negative regulation of protein catabolic process |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0032715 | Biological process | negative regulation of interleukin-6 production |
GO_0043330 | Biological process | response to exogenous dsRNA |
GO_0009615 | Biological process | response to virus |
GO_0070498 | Biological process | interleukin-1-mediated signaling pathway |
GO_0032695 | Biological process | negative regulation of interleukin-12 production |
GO_0070555 | Biological process | response to interleukin-1 |
GO_0010933 | Biological process | positive regulation of macrophage tolerance induction |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0032494 | Biological process | response to peptidoglycan |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0045824 | Biological process | negative regulation of innate immune response |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0043242 | Biological process | negative regulation of protein-containing complex disassembly |
GO_0034122 | Biological process | negative regulation of toll-like receptor signaling pathway |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0043407 | Biological process | negative regulation of MAP kinase activity |
GO_0010936 | Biological process | negative regulation of macrophage cytokine production |
GO_0001819 | Biological process | positive regulation of cytokine production |
GO_0006468 | Biological process | protein phosphorylation |
GO_0008063 | Biological process | Toll signaling pathway |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0001960 | Biological process | negative regulation of cytokine-mediated signaling pathway |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0043244 | Biological process | regulation of protein-containing complex disassembly |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | IRAK3 |
Protein name | Interleukin-1 receptor-associated kinase 3 (IRAK-3) (IL-1 receptor-associated kinase M) (IRAK-M) (Inactive IL-1 receptor-associated kinase 3) Interleukin 1 receptor associated kinase 3 |
Synonyms | |
Description | FUNCTION: Putative inactive protein kinase which regulates signaling downstream of immune receptors including IL1R and Toll-like receptors . Inhibits dissociation of IRAK1 and IRAK4 from the Toll-like receptor signaling complex by either inhibiting the phosphorylation of IRAK1 and IRAK4 or stabilizing the receptor complex (By similarity). Upon IL33-induced lung inflammation, positively regulates expression of IL6, CSF3, CXCL2 and CCL5 mRNAs in dendritic cells . . |
Accessions | ENST00000261233.9 [Q9Y616-1] ENST00000545837.1 F5GYN6 Q9Y616 ENST00000457197.2 [Q9Y616-2] |